2025年歐洲心臟病學(xué)會(huì)（ESC）年會(huì)暨世界心臟病學(xué)大會(huì)將于8月29日至9月1日在西班牙馬德里拉開帷幕。ESC 2025大會(huì)以“全球健康（Global Health）”為主題，聚焦“無國(guó)界心臟病學(xué)（Cardiology Beyond Borders）”，深入探討心血管疾病在全球健康格局中的演變趨勢(shì)。大會(huì)將重點(diǎn)關(guān)注心血管領(lǐng)域的新挑戰(zhàn)與機(jī)遇，包括如何利用創(chuàng)新療法應(yīng)對(duì)健康不平等問題，并適應(yīng)不同地區(qū)的醫(yī)療環(huán)境差異。根據(jù)ESC官網(wǎng)公布的初步日程，本屆會(huì)議將設(shè)立10場(chǎng)Hot Line專場(chǎng)和28場(chǎng)Late-Breaking Science會(huì)議。以下是POCKETIN整理的10場(chǎng)Hot Line專場(chǎng)日程概覽，讓我們一起提前了解大會(huì)亮點(diǎn)。

HOT LINE 1

北京時(shí)間：8月29日 17:00-16:00

POTCAST – a Randomized Controlled Trial of Arrhythmia prevention using targeted plasma potassium levels in ICD Patients
POTCAST研究：ICD患者通過靶向調(diào)控血漿鉀水平預(yù)防心律失常的隨機(jī)對(duì)照試驗(yàn)
講者：Christian Jons
AMALFI: Active Monitoring for Atrial Fibrillation
AMALFI研究：房顫的主動(dòng)監(jiān)測(cè)
講者：Louise Bowman DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
DIGIT-HF研究：地高辛用于射血分?jǐn)?shù)降低的心力衰竭患者
講者：Udo Bavendiek
DOUBLE-CHOICE: Anesthesia strategies and self-expanding valve types for TAVI
DOUBLE-CHOICE研究：TAVI術(shù)中麻醉策略與自膨脹瓣膜類型的選擇
講者：Mohamed Abdel-Wahab

HOT LINE 2

北京時(shí)間：8月30日 14:15-15:45

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure
DAPA ACT HF-TIMI 68研究：達(dá)格列凈用于急性心力衰竭住院患者
講者：David Berg

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure

VICTOR研究：維立西呱在慢性心力衰竭患者中的全球研究
講者：Faiez Zannad

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction
VICTOR與VICTORIA研究：維立西呱在射血分?jǐn)?shù)降低的心力衰竭患者中的全球研究
講者：Javed Butler
ODYSSEY-HCM: Mavacamten in nHCM
ODYSSEY-HCM研究：Mavacamten在非梗阻性肥厚型心肌?。╪HCM）患者中的應(yīng)用
講者：Milind Desai

MAPLE-HCM: aficamten vs metoprolol in oHCM
MAPLE-HCM研究：Aficamten vs. 美托洛爾治療梗阻性肥厚型心肌?。╫HCM）
講者：Pablo Garcia-Pavi

HOT LINE 3

北京時(shí)間：8月30日 17:00-18:00

REBOOT-CNIC: betablockers after infarction with LVEF greater than 40%
REBOOT-CNIC研究：LVEF＞40%的心梗后患者使用β受體阻滯劑的研究
講者：Borja Ibanez

THE BETAMI-DANBLOCK TRIAL: RANDOMIZED DISCONTINUATION OF BETA-BLOCKERS AFTER MYOCARDIAL INFARCTION

BETAMI-DANBLOCK研究：心梗后β受體阻滯劑的隨機(jī)停藥研究
講者：Dan Atar

REBOOT/BETAMI/DANBLOCK/CAPITAL-RCT: Beta-Blockers after MI with Mildly Reduced EF (an IPD meta-analysis)
REBOOT/BETAMI/DANBLOCK/CAPITAL-RCT聯(lián)合分析：輕度LVEF降低的心梗后患者β受體阻滯劑治療（個(gè)體數(shù)據(jù)薈萃分析）
講者：Francisco Javier Rossello
REFINE ICD: Efficacy of ICD therapy in higher risk post-MI patients with better-preserved LV function
REFINE ICD研究：LV功能保留的高風(fēng)險(xiǎn)心梗后患者ICD治療的療效
講者：Derek Exner

HOT LINE 4

北京時(shí)間：8月30日 22:15-23:15

BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
BaxHTN研究：醛固酮合成酶抑制劑Baxdrostat在未控制/難治性高血壓患者中的療效與安全性
講者：Bryan William

KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk

KARDIA-3研究：Zilebesiran作為高血壓合并心血管疾病或高風(fēng)險(xiǎn)患者的附加治療
講者：Neha Pagidipati

Essence-TIMI 73b
Essence-TIMI 73b研究
講者：Brian Bergmark
VICTORION-Difference study: Inclisiran-based strategy vs standard of care
VICTORION-Difference研究：基于英克司蘭的治療策略 vs. 標(biāo)準(zhǔn)降脂治療
講者：Ulf Landmesser

HOT LINE 5

北京時(shí)間：8月30日 23:30-00:30

DANCAVAS 2: Screening and intervention to prevent cardiovascular disease and death
DANCAVAS 2研究：篩查與干預(yù)以預(yù)防心血管疾病和死亡
講者：Axel Diederichsen

PREVENT-MINS trial:Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery

PREVENT-MINS研究：伊伐布雷定預(yù)防非心臟手術(shù)后心肌損傷
講者：Wojciech Szczeklik

ABC-AF study - a randomised controlled study of personalised treatment to reduce stroke or death in atrial fibrillation
ABC-AF研究：個(gè)體化治療降低房顫患者卒中或死亡的隨機(jī)對(duì)照研究
講者：Jonas Oldgren
HI-PRO: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
HI-PRO研究：阿哌沙班用于誘發(fā)性靜脈血栓栓塞的延長(zhǎng)治療
講者：Gregory Piazza

HOT LINE 6

北京時(shí)間：8月31日 14:15-15:45

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease
SWEDEPAD 1&2研究：藥物涂層器械對(duì)外周動(dòng)脈疾病患者的影響

The PULSE randomized controlled trial

PULSE隨機(jī)對(duì)照研究
講者：Ovidio De Filippo

The AQUATIC trial
AQUATIC研究
講者：Martine Gilar

The DUAL-ACS Trial: Duration of DAPT in ACS

DUAL-ACS研究：ACS患者DAPT的療程
講者：David Newby

OPTION-STEMI: Timing of complete revascularization during index hospitalization in patients with STEMI and multivessel disease

OPTION-STEMI研究：STEMI合并多支血管病變患者住院期間完全血運(yùn)重建的時(shí)機(jī)
講者：Youngkeun Ahn

HOT LINE 7

北京時(shí)間：8月31日 22:15-23:15

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

NEO-MINDSET研究：ACS患者PCI術(shù)后早期停用阿司匹林
講者：Pedro Lemos

TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI
TAILORED-CHIP研究：復(fù)雜高危PCI患者的個(gè)體化抗血小板治療
講者：Duk-Woo Park

TARGET-FIRST: Early aspirin discontinuation after PCI in acute MI patients

TARGET-FIRST研究：急性心梗患者PCI術(shù)后早期停用阿司匹林
講者：David Newby

DAPT-SHOCK-AMI trial, Cangrelor in cardiogenic shock.

DAPT-SHOCK-AMI研究：心源性休克患者中使用坎格瑞洛
講者：Zuzana Motovska

HOT LINE 8

北京時(shí)間：8月31日 23:30-00:30

ALONE-AF: Discontinuing long-Term oral anticoagulation after successful atrial fibrillation ablation

ALONE-AF研究：房顫成功消融后停用長(zhǎng)期口服抗凝藥
講者：Boyoung Joung

BEAT PAROX AF: a randomized comparison of PFA vs RFA
BEAT PAROX AF研究：脈沖場(chǎng)消融（PFA） vs. 射頻消融（RFA）的隨機(jī)對(duì)照研究
講者：Pierre Jais

CUVIA-PRR: Digital twin-guided rotor ablation for persistent atrial fibrillation

CUVIA-PRR研究：數(shù)字孿生引導(dǎo)下的Rotor消融治療持續(xù)性房顫

HOT LINE 9

北京時(shí)間：9月1日 14:15-15:45

PARACHUTE-HF: Randomized trial comparing sacubitril/valsartan with enalapril in patients with HFrEF caused by chronic Chagas cardiomyopathy

PARACHUTE-HF研究：沙庫(kù)巴曲/纈沙坦 vs. 依那普利治療慢性恰加斯心肌病所致HFrEF的隨機(jī)對(duì)照試驗(yàn)
講者：Renato Lopes

HELP-MI SWEDEHEART – Randomised H. pylori screening after MI
HELP-MI SWEDEHEART研究：心梗后幽門螺桿菌篩查的隨機(jī)研究
講者：Robin Hofmann

Project MHYH: One-Year Results

Project MHYH研究1年結(jié)果
講者：Thomas Crawford

IMPACT-BP Implementation of a Combination Intervention for Sustainable Blood Pressure Control in rural South Africa

IMPACT-BP研究：南非農(nóng)村地區(qū)高血壓綜合干預(yù)的可持續(xù)控制方案
講者：Thomas Andrew Gaziano

HOT LINE 10

北京時(shí)間：9月1日 19:45-21:00

NEWTON-CABG CardioLink-5: Evolocumab and Saphenous Vein Graft Patency

NEWTON-CABG CardioLink-5研究——依洛尤單抗對(duì)CABG中大隱靜脈橋血管通暢率的影響
講者：Subodh Verma

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
TACSI研究：ACS患者CABG術(shù)后雙聯(lián)或單藥抗血小板治療
講者：Anders Jeppsson

The TOP-CABG trial

TOP-CABG研究
講者：袁昕 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

OPINION Trial: 1-Year Outcomes

OPINION研究1年結(jié)果
講者：王楊 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

《心關(guān)注》

將持續(xù)為您帶來會(huì)議最新動(dòng)態(tài)

敬請(qǐng)關(guān)注！